HeartSciences Inc. has announced the grant of a foundational patent by the United States Patent and Trademark Office (USPTO), which covers the estimation of echocardiography parameters indicative of heart function using an ECG. This patent is critical for the diagnosis and early detection of heart disease. The newly granted patent further expands HeartSciences' extensive patent portfolio, which now includes 10 US patents and 34 international patents across key global markets. The company believes this development reinforces its position as a leader in the rapidly growing AI-ECG field.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-080578), on June 03, 2025, and is solely responsible for the information contained therein.